Skip to content

Web based interactive treatment and self-monitoring in hypertension.

Web based interactive treatment and self-monitoring in hypertension. - WISH-trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38248
Enrollment
300
Registered
2011-08-09
Start date
2011-09-06
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovasculaire risicofactoren High blood pressure Hypertension

Interventions

Patients in the intervention group will use a home blood pressure monitor for self-measuring of the blood pressure. These measurments will be transferred to a secured website when the monitor is con

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 80 years. Use of 3 or more antihypertensive medications. Use of 0,1 or 2 antihypertensive medications and a documented BP equal or greater than 140/90 mmHg (non-diabetic patients) Use of 0,1 or 2 antihypertensive medications and a documented BP equal or greater than 130/80 mmHg (diabetic patients) Patients must be able to measure the BP at home and to communicate with the nurse or physician through the web-based system.

Exclusion criteria

Exclusion criteria: Younger than 18 years of age, older than 80 years of age. Not fluent in Dutch or English language Pregnancy Life expectancy less than one year No access to computer with internet Most recent creatinine clearance (24 hour creatinine clearance) lesser than 30 ml/min Class III or IV heart failure

Design outcomes

Primary

MeasureTime frame
- Improvement of systolic and diastolic blood pressure in hypertensive patients in order to reduce clinical events related to high blood pressure, measured with 24-hours ambulatory blood pressure monitor.

Secondary

MeasureTime frame
- Reduction of cardiovascular events - Reducing the amount of anti-hypertensive drugs needed. - Improvement of surrogate cardiovascular risk markers such as weight, waist-hip ratio, serum lipids, diet, physical activity - Improvement of patient satisfaction. - Reducing the number of out patient clinic visits

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)